Pigs expressing the human inhibitory ligand PD-L1 (CD 274) provide a new source of xenogeneic cells and tissues with low immunogenic properties
- PMID: 29446180
- DOI: 10.1111/xen.12387
Pigs expressing the human inhibitory ligand PD-L1 (CD 274) provide a new source of xenogeneic cells and tissues with low immunogenic properties
Abstract
Background: The programmed cell death-1 (PD-1, CD279)/PD-Ligand1 (PD-L1, CD274) receptor system is crucial for controlling the balance between immune activation and induction of tolerance via generation of inhibitory signals. Expression of PD-L1 is associated with reduced immunogenicity and renders cells and tissues to an immune-privileged/tolerogenic state.
Methods: To apply this concept for clinical xenotransplantation, we generated human (h)PD-L1 transgenic pigs and characterized expression and biological function of the transgene at the cellular level.
Results: The hPD-L1 was detected in kidney, heart, and pancreas. In addition, peripheral blood mononuclear cells (PBMC), cultured fibroblasts, and endothelial cells were hPD-L1 positive (hPD-L1+ ). The hPD-L1 levels were increased by the treatment of transgenic cells with human cytokines (eg, TNF-α), suggesting a regulatable mode of transgene expression. Compared to cells from wild-type pigs, hPD-L1+ PBMC had a significantly reduced capacity to stimulate proliferation of human CD4+ T cells. Moreover, fibroblasts from hPD-L1 transgenic pigs were partially protected from cell-mediated lysis by human cytotoxic effector cells.
Conclusions: These data indicate a low immunogenic, immune-protected status of cells from hPD-L1 transgenic pigs. The integration of the hPD-L1 concept into existing multi-transgenic pigs is promising to achieve long-term survival of porcine xenografts in non-human primate recipients.
Keywords: inhibitory ligands; transgenic pigs.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Similar articles
-
Human PD-L1 overexpression decreases xenogeneic human T-cell immune responses towards porcine kidneys.Front Immunol. 2024 Jan 30;15:1279050. doi: 10.3389/fimmu.2024.1279050. eCollection 2024. Front Immunol. 2024. PMID: 38352884 Free PMC article.
-
Pig to rat cell transplantation: reduced cellular and antibody responses to xenografts overexpressing PD-L1.Xenotransplantation. 2014 Nov-Dec;21(6):533-42. doi: 10.1111/xen.12121. Epub 2014 Jul 9. Xenotransplantation. 2014. PMID: 25041075
-
Human PD-L1-overexpressing porcine vascular endothelial cells induce functionally suppressive human CD4+CD25hiFoxp3+ Treg cells.J Leukoc Biol. 2011 Jul;90(1):77-86. doi: 10.1189/jlb.1210691. Epub 2011 Apr 15. J Leukoc Biol. 2011. PMID: 21498584
-
Stimulatory and inhibitory receptor interactions in xenotransplantation.Curr Opin Organ Transplant. 2010 Apr;15(2):219-23. doi: 10.1097/MOT.0b013e328336b8e5. Curr Opin Organ Transplant. 2010. PMID: 20075730 Review.
-
The Role of NK Cells in Pig-to-Human Xenotransplantation.J Immunol Res. 2017;2017:4627384. doi: 10.1155/2017/4627384. Epub 2017 Dec 19. J Immunol Res. 2017. PMID: 29410970 Free PMC article. Review.
Cited by
-
Progress towards xenogenic tolerance.Curr Opin Organ Transplant. 2020 Oct;25(5):457-463. doi: 10.1097/MOT.0000000000000795. Curr Opin Organ Transplant. 2020. PMID: 32796179 Free PMC article. Review.
-
Human PD-L1 overexpression decreases xenogeneic human T-cell immune responses towards porcine kidneys.Front Immunol. 2024 Jan 30;15:1279050. doi: 10.3389/fimmu.2024.1279050. eCollection 2024. Front Immunol. 2024. PMID: 38352884 Free PMC article.
-
Pig Xenotransplantation in Beta Cell Replacement: Addressing Challenges and Harnessing Potential for Type 1 Diabetes Therapy.Transpl Int. 2024 Oct 24;37:13122. doi: 10.3389/ti.2024.13122. eCollection 2024. Transpl Int. 2024. PMID: 39512630 Free PMC article. Review.
-
Cardiac xenotransplantation: a promising way to treat advanced heart failure.Heart Fail Rev. 2022 Jan;27(1):71-91. doi: 10.1007/s10741-020-09989-x. Heart Fail Rev. 2022. PMID: 32572737 Review.
-
Will Genetic Engineering Carry Xenotransplantation of Pig Islets to the Clinic?Curr Diab Rep. 2018 Sep 18;18(11):103. doi: 10.1007/s11892-018-1074-5. Curr Diab Rep. 2018. PMID: 30229378 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials